Review ArticleReview Article
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies
John G. Foster, Matthew D. Blunt, Edward Carter and Stephen G. Ward
David R. Sibley, ASSOCIATE EDITOR, Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
Pharmacological Reviews October 2012, 64 (4) 1027-1054; DOI: https://doi.org/10.1124/pr.110.004051
John G. Foster
Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
Matthew D. Blunt
Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
Edward Carter
Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
Stephen G. Ward
Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
David R. Sibley
Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
Roles: ASSOCIATE EDITOR
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Review ArticleReview Article
INHIBITION OF PI3K IN THE IMMUNE SYSTEM
John G. Foster, Matthew D. Blunt, Edward Carter and Stephen G. Ward
Pharmacological Reviews October 1, 2012, 64 (4) 1027-1054; DOI: https://doi.org/10.1124/pr.110.004051
Jump to section
- Article
- Abstract
- I. Introduction
- II. Phosphoinositide 3-Kinase Signaling Pathway
- III. Role of Phosphoinositide 3-Kinases γ and δ in the Immune System
- IV. Cooperation between Phosphoinositide 3-Kinase Isoforms in the Immune Response
- V. Emergence of Chemical Tools to Target Phosphoinositide 3-Kinase Signaling
- VI. Development of Phosphoinositide 3-Kinase Inhibitors with Which to Target the Immune System
- VII. Therapeutic Potential of Inhibitors Targeting Phosphoinositide 3-Kinase γ and δ For Immune Disorders
- VIII. Beyond the Class I Phosphoinositide 3-Kinase Isoforms: Increased Understanding of a Role for Class II and III Phosphoinositide 3-Kinases in the Immune System
- IX. SH2-Domain Containing Inositol-5-phosphatase-1: An Alternative Target for Selective Modulation of Phosphoinositide 3-Kinase in the Immune System
- X. Manipulation of SH2-Domain Containing Inositol-5-phosphatase-1 Catalytic Activity with Small Molecules
- XI. Conclusions
- Acknowledgments
- Authorship Contributions
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement